Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome

Jyh Ming Jimmy Juang, Tzu Pin Lu, Liang Chuan Lai, Chia Chuan Ho, Yen Bin Liu, Chia Ti Tsai, Lian Yu Lin, Chih Chieh Yu, Wen Jone Chen, Fu Tien Chiang, Shih Fan Sherri Yeh, Ling Ping Lai, Eric Y. Chuang, Jiunn Lee Lin

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Brugada syndrome (BrS) is one of the ion channelopathies associated with sudden cardiac death (SCD). The most common BrS-associated gene (SCN5A) only accounts for approximately 20-25% of BrS patients. This study aims to identify novel mutations across human ion channels in non-familial BrS patients without SCN5A variants through disease-targeted sequencing. We performed disease-targeted multi-gene sequencing across 133 human ion channel genes and 12 reported BrS-associated genes in 15 unrelated, non-familial BrS patients withoutSCN5A variants. Candidate variants were validated by mass spectrometry and Sanger sequencing. Five de novo mutations were identified in four genes (SCNN1A, KCNJ16, KCNB2, and KCNT1) in three BrS patients (20%). Two of the three patients presented SCD and one had syncope. Interestingly, the two patients presented with SCD had compound mutations (SCNN1A:Arg350Gln and KCNB2:Glu522Lys; SCNN1A:Arg597∗ and KCNJ16:Ser261Gly). Importantly, two SCNN1A mutations were identified from different families. The KCNT1:Arg1106Gln mutation was identified in a patient with syncope. Bioinformatics algorithms predicted severe functional interruptions in these four mutation loci, suggesting their pivotal roles in BrS. This study identified four novel BrS-associated genes and indicated the effectiveness of this disease-targeted sequencing across ion channel genes for non-familial BrS patients without SCN5A variants.

Original languageEnglish
Article number6733
JournalScientific Reports
Volume4
DOIs
Publication statusPublished - Oct 23 2014
Externally publishedYes

Fingerprint

Brugada Syndrome
Ion Channels
Mutation
Genes
Sudden Cardiac Death
Syncope
Channelopathies
Computational Biology
Mass Spectrometry
Ions

ASJC Scopus subject areas

  • General

Cite this

Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome. / Juang, Jyh Ming Jimmy; Lu, Tzu Pin; Lai, Liang Chuan; Ho, Chia Chuan; Liu, Yen Bin; Tsai, Chia Ti; Lin, Lian Yu; Yu, Chih Chieh; Chen, Wen Jone; Chiang, Fu Tien; Yeh, Shih Fan Sherri; Lai, Ling Ping; Chuang, Eric Y.; Lin, Jiunn Lee.

In: Scientific Reports, Vol. 4, 6733, 23.10.2014.

Research output: Contribution to journalArticle

Juang, JMJ, Lu, TP, Lai, LC, Ho, CC, Liu, YB, Tsai, CT, Lin, LY, Yu, CC, Chen, WJ, Chiang, FT, Yeh, SFS, Lai, LP, Chuang, EY & Lin, JL 2014, 'Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome', Scientific Reports, vol. 4, 6733. https://doi.org/10.1038/srep06733
Juang, Jyh Ming Jimmy ; Lu, Tzu Pin ; Lai, Liang Chuan ; Ho, Chia Chuan ; Liu, Yen Bin ; Tsai, Chia Ti ; Lin, Lian Yu ; Yu, Chih Chieh ; Chen, Wen Jone ; Chiang, Fu Tien ; Yeh, Shih Fan Sherri ; Lai, Ling Ping ; Chuang, Eric Y. ; Lin, Jiunn Lee. / Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome. In: Scientific Reports. 2014 ; Vol. 4.
@article{40b8a0e949cb4938b180be5ad79fb1d2,
title = "Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome",
abstract = "Brugada syndrome (BrS) is one of the ion channelopathies associated with sudden cardiac death (SCD). The most common BrS-associated gene (SCN5A) only accounts for approximately 20-25{\%} of BrS patients. This study aims to identify novel mutations across human ion channels in non-familial BrS patients without SCN5A variants through disease-targeted sequencing. We performed disease-targeted multi-gene sequencing across 133 human ion channel genes and 12 reported BrS-associated genes in 15 unrelated, non-familial BrS patients withoutSCN5A variants. Candidate variants were validated by mass spectrometry and Sanger sequencing. Five de novo mutations were identified in four genes (SCNN1A, KCNJ16, KCNB2, and KCNT1) in three BrS patients (20{\%}). Two of the three patients presented SCD and one had syncope. Interestingly, the two patients presented with SCD had compound mutations (SCNN1A:Arg350Gln and KCNB2:Glu522Lys; SCNN1A:Arg597∗ and KCNJ16:Ser261Gly). Importantly, two SCNN1A mutations were identified from different families. The KCNT1:Arg1106Gln mutation was identified in a patient with syncope. Bioinformatics algorithms predicted severe functional interruptions in these four mutation loci, suggesting their pivotal roles in BrS. This study identified four novel BrS-associated genes and indicated the effectiveness of this disease-targeted sequencing across ion channel genes for non-familial BrS patients without SCN5A variants.",
keywords = "Brugada syndrome, epithelial sodium channel, inwardly rectifying potassium channel, KCNB2 protein, human, genetic association",
author = "Juang, {Jyh Ming Jimmy} and Lu, {Tzu Pin} and Lai, {Liang Chuan} and Ho, {Chia Chuan} and Liu, {Yen Bin} and Tsai, {Chia Ti} and Lin, {Lian Yu} and Yu, {Chih Chieh} and Chen, {Wen Jone} and Chiang, {Fu Tien} and Yeh, {Shih Fan Sherri} and Lai, {Ling Ping} and Chuang, {Eric Y.} and Lin, {Jiunn Lee}",
year = "2014",
month = "10",
day = "23",
doi = "10.1038/srep06733",
language = "English",
volume = "4",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome

AU - Juang, Jyh Ming Jimmy

AU - Lu, Tzu Pin

AU - Lai, Liang Chuan

AU - Ho, Chia Chuan

AU - Liu, Yen Bin

AU - Tsai, Chia Ti

AU - Lin, Lian Yu

AU - Yu, Chih Chieh

AU - Chen, Wen Jone

AU - Chiang, Fu Tien

AU - Yeh, Shih Fan Sherri

AU - Lai, Ling Ping

AU - Chuang, Eric Y.

AU - Lin, Jiunn Lee

PY - 2014/10/23

Y1 - 2014/10/23

N2 - Brugada syndrome (BrS) is one of the ion channelopathies associated with sudden cardiac death (SCD). The most common BrS-associated gene (SCN5A) only accounts for approximately 20-25% of BrS patients. This study aims to identify novel mutations across human ion channels in non-familial BrS patients without SCN5A variants through disease-targeted sequencing. We performed disease-targeted multi-gene sequencing across 133 human ion channel genes and 12 reported BrS-associated genes in 15 unrelated, non-familial BrS patients withoutSCN5A variants. Candidate variants were validated by mass spectrometry and Sanger sequencing. Five de novo mutations were identified in four genes (SCNN1A, KCNJ16, KCNB2, and KCNT1) in three BrS patients (20%). Two of the three patients presented SCD and one had syncope. Interestingly, the two patients presented with SCD had compound mutations (SCNN1A:Arg350Gln and KCNB2:Glu522Lys; SCNN1A:Arg597∗ and KCNJ16:Ser261Gly). Importantly, two SCNN1A mutations were identified from different families. The KCNT1:Arg1106Gln mutation was identified in a patient with syncope. Bioinformatics algorithms predicted severe functional interruptions in these four mutation loci, suggesting their pivotal roles in BrS. This study identified four novel BrS-associated genes and indicated the effectiveness of this disease-targeted sequencing across ion channel genes for non-familial BrS patients without SCN5A variants.

AB - Brugada syndrome (BrS) is one of the ion channelopathies associated with sudden cardiac death (SCD). The most common BrS-associated gene (SCN5A) only accounts for approximately 20-25% of BrS patients. This study aims to identify novel mutations across human ion channels in non-familial BrS patients without SCN5A variants through disease-targeted sequencing. We performed disease-targeted multi-gene sequencing across 133 human ion channel genes and 12 reported BrS-associated genes in 15 unrelated, non-familial BrS patients withoutSCN5A variants. Candidate variants were validated by mass spectrometry and Sanger sequencing. Five de novo mutations were identified in four genes (SCNN1A, KCNJ16, KCNB2, and KCNT1) in three BrS patients (20%). Two of the three patients presented SCD and one had syncope. Interestingly, the two patients presented with SCD had compound mutations (SCNN1A:Arg350Gln and KCNB2:Glu522Lys; SCNN1A:Arg597∗ and KCNJ16:Ser261Gly). Importantly, two SCNN1A mutations were identified from different families. The KCNT1:Arg1106Gln mutation was identified in a patient with syncope. Bioinformatics algorithms predicted severe functional interruptions in these four mutation loci, suggesting their pivotal roles in BrS. This study identified four novel BrS-associated genes and indicated the effectiveness of this disease-targeted sequencing across ion channel genes for non-familial BrS patients without SCN5A variants.

KW - Brugada syndrome

KW - epithelial sodium channel

KW - inwardly rectifying potassium channel

KW - KCNB2 protein, human

KW - genetic association

UR - http://www.scopus.com/inward/record.url?scp=84940960945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940960945&partnerID=8YFLogxK

U2 - 10.1038/srep06733

DO - 10.1038/srep06733

M3 - Article

C2 - 25339316

AN - SCOPUS:84940960945

VL - 4

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 6733

ER -